Brooks Laboratories Limited Total Assets

Latest as of September 2025: Rs1.40 Billion INR ≈ $15.13 Million USD

Brooks Laboratories Limited total assets. Based on the latest financial reports, Brooks Laboratories Limited (BROOKS) holds total assets worth Rs1.40 Billion INR (≈ $15.13 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see BROOKS market cap overview for the company's overall valuation and market capitalisation.

Total Assets of Brooks Laboratories Limited (2007–2025)

Total assets of Brooks Laboratories Limited from 2007 to 2025. This chart illustrates how Brooks Laboratories Limited's total assets have evolved over time, based on quarterly financial data. See Brooks Laboratories Limited (BROOKS) stock price for real-time trading data and today's change.

Brooks Laboratories Limited - Asset Composition Analysis

Brooks Laboratories Limited Total Assets Breakdown (March 2025)

Brooks Laboratories Limited total assets breakdown as of March 2025. Brooks Laboratories Limited's total assets of Rs1.40 Billion consist of 27.4% current assets and 72.6% non-current assets.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs0.00	1.0%
Accounts Receivable	Rs199.92 Million	16.2%
Inventory	Rs92.05 Million	7.4%
Property, Plant & Equipment	Rs139.72 Million	11.3%
Intangible Assets	Rs91.00K	0.0%
Goodwill	Rs0.00	0.0%

Asset Composition Trend (2007–2025)

This chart illustrates how Brooks Laboratories Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Brooks Laboratories Limited (BROOKS) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Brooks Laboratories Limited's current assets represent 27.4% of total assets in 2025, a decrease from 43.5% in 2007.
Cash Position: Cash and equivalents constituted 1.0% of total assets in 2025, down from 1.0% in 2007.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2007.
Asset Diversification: The largest asset category is accounts receivable at 16.2% of total assets.

Brooks Laboratories Limited Competitors by Total Assets

Key competitors of Brooks Laboratories Limited based on total assets are shown below.

Company	Country	Total Assets
Jiangsu Hengrui Medicine Co Ltd SHG:600276	China	CN¥68.33 Billion
Sandoz Group AG SW:SDZ	Switzerland	CHF22.86 Billion
H Lundbeck A/S CO:HLUN-B	Denmark	Dkr54.01 Billion
Changchun High & New Technology Industries Group Inc SHE:000661	China	CN¥30.77 Billion
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	China	CN¥17.01 Billion
Kangmei Pharmaceutical Co Ltd SHG:600518	China	CN¥13.68 Billion
Viyash Scientific Limited NSE:SEQUENT	India	Rs17.26 Billion
Anhui Fengyuan Pharmaceutical Co Ltd SHE:000153	China	CN¥5.11 Billion

Brooks Laboratories Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.73	1.32	0.93
Quick Ratio	1.38	0.99	0.46
Cash Ratio	0.00	0.01	0.00
Working Capital	Rs159.30 Million	Rs91.66 Million	Rs-44.99 Million

Brooks Laboratories Limited - Advanced Valuation Insights

This section examines the relationship between Brooks Laboratories Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.27
Latest Market Cap to Assets Ratio	0.02
Asset Growth Rate (YoY)	36.8%
Total Assets	Rs1.24 Billion
Market Capitalization	$20.86 Million USD

Valuation Analysis

Below Book Valuation: The market values Brooks Laboratories Limited's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Brooks Laboratories Limited's assets grew by 36.8% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Brooks Laboratories Limited (2007–2025)

The table below shows the annual total assets of Brooks Laboratories Limited from 2007 to 2025.

Year	Total Assets	Change
2025-03-31	Rs1.24 Billion ≈ $13.38 Million	+36.76%
2024-03-31	Rs904.45 Million ≈ $9.78 Million	-17.47%
2023-03-31	Rs1.10 Billion ≈ $11.85 Million	-44.06%
2022-03-31	Rs1.96 Billion ≈ $21.19 Million	+20.87%
2021-03-31	Rs1.62 Billion ≈ $17.53 Million	+2.67%
2020-03-31	Rs1.58 Billion ≈ $17.07 Million	-6.01%
2019-03-31	Rs1.68 Billion ≈ $18.16 Million	-2.73%
2018-03-31	Rs1.73 Billion ≈ $18.67 Million	+5.87%
2017-03-31	Rs1.63 Billion ≈ $17.64 Million	+6.92%
2016-03-31	Rs1.53 Billion ≈ $16.50 Million	+12.87%
2015-03-31	Rs1.35 Billion ≈ $14.62 Million	-3.77%
2014-03-31	Rs1.40 Billion ≈ $15.19 Million	+6.67%
2013-03-31	Rs1.32 Billion ≈ $14.24 Million	+24.44%
2012-03-31	Rs1.06 Billion ≈ $11.44 Million	+158.92%
2011-03-31	Rs408.64 Million ≈ $4.42 Million	+9.68%
2010-03-31	Rs372.57 Million ≈ $4.03 Million	+16.00%
2009-03-31	Rs321.19 Million ≈ $3.47 Million	+26.54%
2008-03-31	Rs253.81 Million ≈ $2.74 Million	+69.46%
2007-03-31	Rs149.78 Million ≈ $1.62 Million	--

About Brooks Laboratories Limited

NSE:BROOKS India Drug Manufacturers - Specialty & Generic

Market Cap

$20.86 Million

Rs1.93 Billion INR

Market Cap Rank

#24821 Global

#1373 in India

Share Price

Rs65.49

Change (1 day)

+1.44%

52-Week Range

Rs37.11 - Rs109.82

All Time High

Rs194.97